data_2m1t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m1t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 62' ' ' LEU . 73.7 p . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.208 0.528 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.9 mt 70.35 0.69 3.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.997 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -168.73 60.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.83 -2.98 0.31 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.73 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.52 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -128.29 -5.67 5.41 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.88 -60.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.434 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.93 -53.96 0.08 OUTLIER Pre-proline 0 N--CA 1.481 1.123 0 CA-C-N 117.939 0.336 . . . . 0.0 111.189 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.48 -9.42 21.49 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.445 1.43 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.684 ' NE2' HH21 ' A' ' 72' ' ' ARG . 11.9 pt20 -57.71 -25.71 60.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.615 0.722 . . . . 0.0 109.278 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.37 -46.42 76.48 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.296 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.01 38.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.572 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 11.8 t -141.6 -45.97 0.36 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.289 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.684 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -105.14 -10.83 16.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.738 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.65 -35.42 6.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.529 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.87 -56.88 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.574 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 8.1 mp -62.92 -39.85 95.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.532 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.983 0.421 . . . . 0.0 110.134 179.724 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 62' ' ' LEU . 70.7 p . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.3 mt 67.78 -2.08 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.693 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.5 OUTLIER -165.29 61.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.16 -5.42 0.39 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.781 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.568 ' CZ ' ' NH1' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -126.15 -2.15 7.02 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 mt -128.06 -64.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -54.32 0.14 Allowed Pre-proline 0 N--CA 1.478 0.972 0 CA-C-N 117.987 0.358 . . . . 0.0 111.055 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' O ' ' SG ' ' A' ' 71' ' ' CYS . 7.4 Cg_exo -74.14 -11.58 23.22 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.58 1.52 . . . . 0.0 110.618 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.678 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.1 pt20 -56.47 -22.85 35.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.883 0.849 . . . . 0.0 108.738 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.21 -39.37 86.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.849 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.81 34.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 33.9 m -134.89 -46.32 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.678 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -99.87 -9.7 22.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.35 -35.21 6.85 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.247 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.73 -58.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.638 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -64.75 -22.8 67.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.832 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.52 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.028 0.442 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.11 0.31 3.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.819 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -167.42 59.2 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.531 ' O ' ' NH2' ' A' ' 64' ' ' ARG . . . 151.92 -3.28 0.4 Allowed Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.128 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -131.12 -3.38 3.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.388 -0.226 . . . . 0.0 110.388 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.3 mt -130.82 -63.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -63.14 0.11 Allowed Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.448 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.1 -6.2 17.69 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 120.931 1.087 . . . . 0.0 111.26 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.693 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.0 pt20 -56.24 -23.16 34.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.05 -39.59 86.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.705 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -95.82 36.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.584 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -137.31 -44.33 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.693 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -105.88 -10.71 16.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.805 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.6 -40.0 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.593 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.04 -55.18 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.462 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 75' ' ' LEU . 3.0 mm? -63.52 -39.36 94.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.339 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 . . . . . 0 C--O 1.218 -0.58 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.079 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.138 0.494 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 69.76 -7.58 0.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.923 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -159.91 52.47 0.34 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' NH2' ' A' ' 72' ' ' ARG . . . 161.67 -5.71 0.09 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.123 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.76 ' HE ' HH22 ' A' ' 72' ' ' ARG . 0.3 OUTLIER -129.67 0.3 4.92 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 mt -136.71 -69.36 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -58.79 0.25 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.823 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -71.4 -13.48 30.53 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.233 1.289 . . . . 0.0 109.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.631 ' CG ' HH21 ' A' ' 72' ' ' ARG . 3.8 tm0? -58.79 -46.04 88.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.141 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.9 mt -62.35 -39.04 91.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.055 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.72 29.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 t -132.46 -44.35 0.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.76 HH22 ' HE ' ' A' ' 64' ' ' ARG . 1.1 mpp_? -101.95 -11.1 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.905 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -110.87 -28.43 8.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.554 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -107.03 -58.87 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.94 -43.85 97.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.69 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.916 -179.533 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 62' ' ' LEU . 82.5 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.048 0.452 . . . . 0.0 110.563 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.3 mt 68.75 -2.31 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.6 OUTLIER -166.32 62.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.67 -4.24 0.55 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.726 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -126.57 -5.84 6.41 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 mt -124.98 -63.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.76 -54.3 0.14 Allowed Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 117.978 0.354 . . . . 0.0 111.23 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.68 -12.5 22.24 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.662 1.574 . . . . 0.0 110.839 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.94 -23.22 30.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt -61.09 -38.96 88.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.456 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.46 29.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.525 ' CB ' HH21 ' A' ' 72' ' ' ARG . 78.4 m -134.43 -61.05 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.525 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -73.14 -26.99 61.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.169 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.27 -8.34 17.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.464 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.66 -67.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.24 -39.02 93.42 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.386 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.526 -179.139 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.952 0.406 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.8 mt 71.85 6.53 5.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.789 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.429 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 1.4 pp -175.61 55.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.301 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.44 -1.8 0.25 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.13 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 68' ' ' GLN . 12.8 tpp85 -134.26 -0.49 3.0 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 mm -128.12 -67.33 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -58.88 0.14 Allowed Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 122.217 -0.302 . . . . 0.0 111.512 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.15 -4.46 14.35 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 120.958 1.105 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 64' ' ' ARG . 8.1 pt20 -61.49 -23.5 65.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.85 -38.61 86.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.36 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.22 29.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.834 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.527 ' CB ' HH21 ' A' ' 72' ' ' ARG . 85.4 m -136.98 -53.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.527 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -80.43 -21.43 42.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.826 179.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 mt -110.0 -21.03 12.51 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.797 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -107.56 -64.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.4 mt -62.76 -39.87 95.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.469 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 . . . . . 0 C--O 1.219 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.075 179.837 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 62' ' ' LEU . 73.7 p -118.19 145.21 45.13 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.208 0.528 . . . . 0.0 111.13 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.9 mt 70.35 0.69 3.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.997 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -168.73 60.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.83 -2.98 0.31 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.73 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.52 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -128.29 -5.67 5.41 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.88 -60.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.434 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.93 -53.96 0.08 OUTLIER Pre-proline 0 N--CA 1.481 1.123 0 CA-C-N 117.939 0.336 . . . . 0.0 111.189 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.48 -9.42 21.49 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.445 1.43 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.684 ' NE2' HH21 ' A' ' 72' ' ' ARG . 11.9 pt20 -57.71 -25.71 60.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.615 0.722 . . . . 0.0 109.278 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.37 -46.42 76.48 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.296 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.01 38.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.572 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 11.8 t -141.6 -45.97 0.36 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.289 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.684 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -105.14 -10.83 16.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.738 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.65 -35.42 6.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.529 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.87 -56.88 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.574 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 80' ' ' ASP . 8.1 mp -62.92 -39.85 95.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.532 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -60.87 -39.59 89.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.983 0.421 . . . . 0.0 110.134 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.97 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.811 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 80' ' ' ASP . 78.7 p -86.85 43.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.739 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 pt 38.32 25.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' LEU . 65.4 t0 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.569 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.575 ' H1 ' ' CD1' ' A' ' 62' ' ' LEU . 99.3 m-20 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 62' ' ' LEU . 70.7 p -98.53 145.11 27.13 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.172 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.3 mt 67.78 -2.08 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.693 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.575 ' CD1' ' H1 ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER -165.29 61.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.16 -5.42 0.39 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.781 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.568 ' CZ ' ' NH1' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -126.15 -2.15 7.02 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 mt -128.06 -64.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.85 -54.32 0.14 Allowed Pre-proline 0 N--CA 1.478 0.972 0 CA-C-N 117.987 0.358 . . . . 0.0 111.055 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' O ' ' SG ' ' A' ' 71' ' ' CYS . 7.4 Cg_exo -74.14 -11.58 23.22 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.58 1.52 . . . . 0.0 110.618 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.678 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.1 pt20 -56.47 -22.85 35.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.883 0.849 . . . . 0.0 108.738 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.21 -39.37 86.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.849 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.81 34.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.689 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 33.9 m -134.89 -46.32 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.678 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -99.87 -9.7 22.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.35 -35.21 6.85 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.247 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 78' ' ' SER . 43.4 t -99.73 -58.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.638 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -64.75 -22.8 67.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.832 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -60.22 -41.73 93.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.2 m -114.3 -26.9 7.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 46.7 t -61.25 -48.21 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.428 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.68 -12.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.642 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.683 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' OD2' ' NH1' ' A' ' 64' ' ' ARG . 54.9 p30 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.8 p -141.57 136.42 31.06 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.028 0.442 . . . . 0.0 110.459 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 74.11 0.31 3.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.819 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -167.42 59.2 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.531 ' O ' ' NH2' ' A' ' 64' ' ' ARG . . . 151.92 -3.28 0.4 Allowed Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.128 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -131.12 -3.38 3.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.388 -0.226 . . . . 0.0 110.388 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.3 mt -130.82 -63.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -63.14 0.11 Allowed Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.448 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.1 -6.2 17.69 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 120.931 1.087 . . . . 0.0 111.26 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.693 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.0 pt20 -56.24 -23.16 34.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.05 -39.59 86.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.705 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -95.82 36.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.584 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -137.31 -44.33 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.693 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -105.88 -10.71 16.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.805 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.6 -40.0 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.593 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.04 -55.18 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.462 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 75' ' ' LEU . 3.0 mm? -63.52 -39.36 94.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.339 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 80' ' ' ASP . 72.2 ttp85 -59.81 -42.74 94.16 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.079 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 52.8 t -61.71 -46.61 88.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.831 0.348 . . . . 0.0 111.206 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.5 m -67.29 -42.07 84.35 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.2 tt -95.63 -30.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.801 0.334 . . . . 0.0 111.625 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 76' ' ' ARG . 1.2 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.861 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 p30 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -178.03 102.27 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.029 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 69.76 -7.58 0.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.923 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -159.91 52.47 0.34 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' NH2' ' A' ' 72' ' ' ARG . . . 161.67 -5.71 0.09 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.123 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.76 ' HE ' HH22 ' A' ' 72' ' ' ARG . 0.3 OUTLIER -129.67 0.3 4.92 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 mt -136.71 -69.36 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -58.79 0.25 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.823 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -71.4 -13.48 30.53 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.233 1.289 . . . . 0.0 109.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.631 ' CG ' HH21 ' A' ' 72' ' ' ARG . 3.8 tm0? -58.79 -46.04 88.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.141 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.9 mt -62.35 -39.04 91.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.055 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.72 29.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 t -132.46 -44.35 0.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.76 HH22 ' HE ' ' A' ' 64' ' ' ARG . 1.1 mpp_? -101.95 -11.1 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.905 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -110.87 -28.43 8.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.554 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -107.03 -58.87 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.94 -43.85 97.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.69 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -81.8 6.76 14.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.916 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 41.0 t -116.92 -50.75 2.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -61.21 -43.94 98.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.425 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.8 pt -118.86 -8.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.587 0.232 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.552 -179.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' H1 ' ' H ' ' A' ' 60' ' ' THR . 99.7 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 62' ' ' LEU . 82.5 p -116.47 144.77 43.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.048 0.452 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.3 mt 68.75 -2.31 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.6 OUTLIER -166.32 62.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.67 -4.24 0.55 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.726 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -126.57 -5.84 6.41 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 mt -124.98 -63.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.76 -54.3 0.14 Allowed Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 117.978 0.354 . . . . 0.0 111.23 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.68 -12.5 22.24 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.662 1.574 . . . . 0.0 110.839 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.94 -23.22 30.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt -61.09 -38.96 88.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.456 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.46 29.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.525 ' CB ' HH21 ' A' ' 72' ' ' ARG . 78.4 m -134.43 -61.05 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.525 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -73.14 -26.99 61.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.169 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.27 -8.34 17.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.464 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 78' ' ' SER . 74.8 t -120.66 -67.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.24 -39.02 93.42 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.386 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 34.7 ttm180 -81.5 -13.21 58.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.526 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.78 -53.03 2.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 74' ' ' VAL . 74.9 m -60.98 -41.02 95.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.3 -8.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.606 0.241 . . . . 0.0 111.629 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 76' ' ' ARG . 98.7 m-20 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.718 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' H3 ' ' H ' ' A' ' 60' ' ' THR . 99.1 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.425 ' H ' ' H3 ' ' A' ' 59' ' ' ASP . 81.9 p -117.6 148.87 41.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.952 0.406 . . . . 0.0 110.548 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.8 mt 71.85 6.53 5.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.789 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.429 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 1.4 pp -175.61 55.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.301 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.44 -1.8 0.25 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.13 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 68' ' ' GLN . 12.8 tpp85 -134.26 -0.49 3.0 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 mm -128.12 -67.33 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -58.88 0.14 Allowed Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 122.217 -0.302 . . . . 0.0 111.512 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.15 -4.46 14.35 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 120.958 1.105 . . . . 0.0 111.47 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 64' ' ' ARG . 8.1 pt20 -61.49 -23.5 65.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.85 -38.61 86.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.36 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.22 29.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.834 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.527 ' CB ' HH21 ' A' ' 72' ' ' ARG . 85.4 m -136.98 -53.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.527 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -80.43 -21.43 42.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.826 179.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 mt -110.0 -21.03 12.51 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.797 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -107.56 -64.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.4 mt -62.76 -39.87 95.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.469 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 80' ' ' ASP . 63.8 ttm-85 -61.74 -44.48 96.83 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.075 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.4 m -64.34 -41.64 96.67 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.443 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -70.17 -41.2 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.41 -32.52 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.009 0.433 . . . . 0.0 110.355 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 76' ' ' ARG . 66.1 t0 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.934 -1.031 . . . . 0.0 111.009 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.208 0.528 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.9 mt 70.35 0.69 3.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.997 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -168.73 60.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.83 -2.98 0.31 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.73 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.554 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -128.29 -5.67 5.41 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 66' ' ' LEU . 18.9 mt -124.88 -60.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.434 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -106.93 -53.96 0.08 OUTLIER Pre-proline 0 N--CA 1.481 1.123 0 CA-C-N 117.939 0.336 . . . . 0.0 111.189 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.0 Cg_exo -74.48 -9.42 21.49 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.445 1.43 . . . . 0.0 110.544 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.694 ' NE2' HH21 ' A' ' 72' ' ' ARG . 11.9 pt20 -57.71 -25.71 60.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.615 0.722 . . . . 0.0 109.278 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.37 -46.42 76.48 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.296 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 75' ' ' LEU . 27.1 m -88.01 38.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.572 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 11.8 t -141.6 -45.97 0.36 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.289 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.694 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -105.14 -10.83 16.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.738 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.65 -35.42 6.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.529 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.87 -56.88 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.574 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 75' ' ' LEU . 8.1 mp -62.92 -39.85 95.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.532 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.983 0.421 . . . . 0.0 110.134 179.724 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 62' ' ' LEU . 70.7 p . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.3 mt 67.78 -2.08 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.693 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.5 OUTLIER -165.29 61.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.16 -5.42 0.39 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.781 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.568 ' CZ ' ' NH1' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -126.15 -2.15 7.02 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 HD23 ' A' ' 66' ' ' LEU . 19.1 mt -128.06 -64.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.487 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.85 -54.32 0.14 Allowed Pre-proline 0 N--CA 1.478 0.972 0 CA-C-N 117.987 0.358 . . . . 0.0 111.055 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.4 Cg_exo -74.14 -11.58 23.22 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.58 1.52 . . . . 0.0 110.618 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 10.8 pt20 -56.47 -22.85 35.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.883 0.849 . . . . 0.0 108.738 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.21 -39.37 86.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.849 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 67' ' ' PRO . 25.5 m -95.81 34.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.689 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -134.89 -46.32 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.568 ' NH1' ' CZ ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -99.87 -9.7 22.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.35 -35.21 6.85 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.247 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.73 -58.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.638 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -64.75 -22.8 67.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.832 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.52 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.028 0.442 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 74.11 0.31 3.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.819 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -167.42 59.2 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.531 ' O ' ' NH2' ' A' ' 64' ' ' ARG . . . 151.92 -3.28 0.4 Allowed Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.128 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -131.12 -3.38 3.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.388 -0.226 . . . . 0.0 110.388 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 61' ' ' LEU . 17.3 mt -130.82 -63.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -97.82 -63.14 0.11 Allowed Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.448 -178.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 70' ' ' VAL . 93.8 Cg_endo -75.1 -6.2 17.69 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 120.931 1.087 . . . . 0.0 111.26 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.703 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.0 pt20 -56.24 -23.16 34.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.05 -39.59 86.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.705 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 67' ' ' PRO . 31.0 m -95.82 36.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.584 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -137.31 -44.33 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.703 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -105.88 -10.71 16.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.805 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.6 -40.0 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.593 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.04 -55.18 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.462 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 75' ' ' LEU . 3.0 mm? -63.52 -39.36 94.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.339 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 . . . . . 0 C--O 1.218 -0.58 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.079 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.138 0.494 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 69.76 -7.58 0.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.923 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -159.91 52.47 0.34 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' NH2' ' A' ' 72' ' ' ARG . . . 161.67 -5.71 0.09 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.123 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.776 ' HE ' HH22 ' A' ' 72' ' ' ARG . 0.3 OUTLIER -129.67 0.3 4.92 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 61' ' ' LEU . 16.3 mt -136.71 -69.36 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -89.2 -58.79 0.25 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.823 -178.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -71.4 -13.48 30.53 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.233 1.289 . . . . 0.0 109.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.651 ' CG ' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -58.79 -46.04 88.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.141 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.9 mt -62.35 -39.04 91.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.055 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.72 29.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 t -132.46 -44.35 0.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.776 HH22 ' HE ' ' A' ' 64' ' ' ARG . 1.1 mpp_? -101.95 -11.1 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.905 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -110.87 -28.43 8.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.554 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -107.03 -58.87 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.94 -43.85 97.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.69 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.916 -179.533 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' LEU . 82.5 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.048 0.452 . . . . 0.0 110.563 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.3 mt 68.75 -2.31 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.6 OUTLIER -166.32 62.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.67 -4.24 0.55 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.726 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -126.57 -5.84 6.41 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 HD23 ' A' ' 66' ' ' LEU . 21.1 mt -124.98 -63.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.507 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.76 -54.3 0.14 Allowed Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 117.978 0.354 . . . . 0.0 111.23 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 70' ' ' VAL . 5.6 Cg_exo -74.68 -12.5 22.24 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.662 1.574 . . . . 0.0 110.839 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.94 -23.22 30.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt -61.09 -38.96 88.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.456 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 67' ' ' PRO . 29.0 m -94.46 29.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' CB ' HH21 ' A' ' 72' ' ' ARG . 78.4 m -134.43 -61.05 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.534 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -73.14 -26.99 61.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.169 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.27 -8.34 17.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.464 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.66 -67.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.24 -39.02 93.42 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.386 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.526 -179.139 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.952 0.406 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.8 mt 71.85 6.53 5.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.789 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 62' ' ' LEU . 1.4 pp -175.61 55.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.301 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.44 -1.8 0.25 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.13 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.696 ' O ' HD13 ' A' ' 65' ' ' ILE . 12.8 tpp85 -134.26 -0.49 3.0 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 64' ' ' ARG . 8.9 mm -128.12 -67.33 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -98.68 -58.88 0.14 Allowed Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 122.217 -0.302 . . . . 0.0 111.512 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 70' ' ' VAL . 87.0 Cg_endo -78.15 -4.46 14.35 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 120.958 1.105 . . . . 0.0 111.47 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 64' ' ' ARG . 8.1 pt20 -61.49 -23.5 65.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.85 -38.61 86.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.36 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 67' ' ' PRO . 30.5 m -93.22 29.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.834 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.537 ' CB ' HH21 ' A' ' 72' ' ' ARG . 85.4 m -136.98 -53.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.537 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -80.43 -21.43 42.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.826 179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 mt -110.0 -21.03 12.51 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.797 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -107.56 -64.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.4 mt -62.76 -39.87 95.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.469 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 . . . . . 0 C--O 1.219 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.075 179.837 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -118.19 145.21 45.13 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.208 0.528 . . . . 0.0 111.13 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.9 mt 70.35 0.69 3.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.997 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -168.73 60.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.83 -2.98 0.31 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.73 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.554 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -128.29 -5.67 5.41 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 66' ' ' LEU . 18.9 mt -124.88 -60.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.434 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -106.93 -53.96 0.08 OUTLIER Pre-proline 0 N--CA 1.481 1.123 0 CA-C-N 117.939 0.336 . . . . 0.0 111.189 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.0 Cg_exo -74.48 -9.42 21.49 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.445 1.43 . . . . 0.0 110.544 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.694 ' NE2' HH21 ' A' ' 72' ' ' ARG . 11.9 pt20 -57.71 -25.71 60.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.615 0.722 . . . . 0.0 109.278 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.37 -46.42 76.48 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.296 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 75' ' ' LEU . 27.1 m -88.01 38.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.572 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 11.8 t -141.6 -45.97 0.36 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.289 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.694 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -105.14 -10.83 16.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.738 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.65 -35.42 6.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.529 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.87 -56.88 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.574 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 75' ' ' LEU . 8.1 mp -62.92 -39.85 95.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.532 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -60.87 -39.59 89.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.983 0.421 . . . . 0.0 110.134 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.97 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.811 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 80' ' ' ASP . 78.7 p -86.85 43.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.739 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 pt 38.32 25.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' LEU . 65.4 t0 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.569 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 62' ' ' LEU . 70.7 p -98.53 145.11 27.13 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.172 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.3 mt 67.78 -2.08 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.693 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.5 OUTLIER -165.29 61.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.16 -5.42 0.39 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.781 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.568 ' CZ ' ' NH1' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -126.15 -2.15 7.02 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 HD23 ' A' ' 66' ' ' LEU . 19.1 mt -128.06 -64.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.487 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.85 -54.32 0.14 Allowed Pre-proline 0 N--CA 1.478 0.972 0 CA-C-N 117.987 0.358 . . . . 0.0 111.055 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.4 Cg_exo -74.14 -11.58 23.22 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.58 1.52 . . . . 0.0 110.618 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 72' ' ' ARG . 10.8 pt20 -56.47 -22.85 35.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.883 0.849 . . . . 0.0 108.738 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.21 -39.37 86.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.849 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 67' ' ' PRO . 25.5 m -95.81 34.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.689 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -134.89 -46.32 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' NH1' ' CZ ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -99.87 -9.7 22.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.35 -35.21 6.85 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.247 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 78' ' ' SER . 43.4 t -99.73 -58.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.638 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -64.75 -22.8 67.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.832 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -60.22 -41.73 93.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.2 m -114.3 -26.9 7.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 46.7 t -61.25 -48.21 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.428 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.68 -12.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.642 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.683 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' OD2' ' NH1' ' A' ' 64' ' ' ARG . 54.9 p30 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.8 p -141.57 136.42 31.06 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.028 0.442 . . . . 0.0 110.459 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 74.11 0.31 3.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.819 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -167.42 59.2 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.531 ' O ' ' NH2' ' A' ' 64' ' ' ARG . . . 151.92 -3.28 0.4 Allowed Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.128 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -131.12 -3.38 3.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.388 -0.226 . . . . 0.0 110.388 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 61' ' ' LEU . 17.3 mt -130.82 -63.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -97.82 -63.14 0.11 Allowed Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.448 -178.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 70' ' ' VAL . 93.8 Cg_endo -75.1 -6.2 17.69 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 120.931 1.087 . . . . 0.0 111.26 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.703 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.0 pt20 -56.24 -23.16 34.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.05 -39.59 86.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.705 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 67' ' ' PRO . 31.0 m -95.82 36.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.584 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -137.31 -44.33 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.703 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -105.88 -10.71 16.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.805 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.6 -40.0 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.593 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.04 -55.18 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.462 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 75' ' ' LEU . 3.0 mm? -63.52 -39.36 94.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.339 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 80' ' ' ASP . 72.2 ttp85 -59.81 -42.74 94.16 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.079 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 52.8 t -61.71 -46.61 88.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.831 0.348 . . . . 0.0 111.206 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.5 m -67.29 -42.07 84.35 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 75' ' ' LEU . 16.2 tt -95.63 -30.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.801 0.334 . . . . 0.0 111.625 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 76' ' ' ARG . 1.2 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.861 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 p30 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -178.03 102.27 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.029 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 69.76 -7.58 0.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.923 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -159.91 52.47 0.34 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' NH2' ' A' ' 72' ' ' ARG . . . 161.67 -5.71 0.09 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.123 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.776 ' HE ' HH22 ' A' ' 72' ' ' ARG . 0.3 OUTLIER -129.67 0.3 4.92 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 61' ' ' LEU . 16.3 mt -136.71 -69.36 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -89.2 -58.79 0.25 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.823 -178.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -71.4 -13.48 30.53 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.233 1.289 . . . . 0.0 109.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.651 ' CG ' HH21 ' A' ' 72' ' ' ARG . 1.0 OUTLIER -58.79 -46.04 88.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.141 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.9 mt -62.35 -39.04 91.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.055 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.72 29.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 t -132.46 -44.35 0.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.776 HH22 ' HE ' ' A' ' 64' ' ' ARG . 1.1 mpp_? -101.95 -11.1 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.905 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -110.87 -28.43 8.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.554 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -107.03 -58.87 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.94 -43.85 97.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.69 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -81.8 6.76 14.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.916 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 41.0 t -116.92 -50.75 2.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -61.21 -43.94 98.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.425 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.8 pt -118.86 -8.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.587 0.232 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.552 -179.876 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB3' HH21 ' A' ' 64' ' ' ARG . 99.7 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' LEU . 82.5 p -116.47 144.77 43.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.048 0.452 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.3 mt 68.75 -2.31 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.6 OUTLIER -166.32 62.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.67 -4.24 0.55 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.726 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 59' ' ' ASP . 13.3 tpp85 -126.57 -5.84 6.41 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 HD23 ' A' ' 66' ' ' LEU . 21.1 mt -124.98 -63.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.507 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.76 -54.3 0.14 Allowed Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 117.978 0.354 . . . . 0.0 111.23 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 70' ' ' VAL . 5.6 Cg_exo -74.68 -12.5 22.24 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.662 1.574 . . . . 0.0 110.839 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.94 -23.22 30.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt -61.09 -38.96 88.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.456 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 67' ' ' PRO . 29.0 m -94.46 29.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' CB ' HH21 ' A' ' 72' ' ' ARG . 78.4 m -134.43 -61.05 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.534 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -73.14 -26.99 61.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.169 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.27 -8.34 17.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.464 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.66 -67.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.24 -39.02 93.42 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.386 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 34.7 ttm180 -81.5 -13.21 58.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.526 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.78 -53.03 2.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -60.98 -41.02 95.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.3 -8.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.606 0.241 . . . . 0.0 111.629 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 76' ' ' ARG . 98.7 m-20 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.718 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB3' HH21 ' A' ' 64' ' ' ARG . 99.1 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -117.6 148.87 41.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.952 0.406 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.8 mt 71.85 6.53 5.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.789 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 62' ' ' LEU . 1.4 pp -175.61 55.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.301 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.44 -1.8 0.25 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.13 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.696 ' O ' HD13 ' A' ' 65' ' ' ILE . 12.8 tpp85 -134.26 -0.49 3.0 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 64' ' ' ARG . 8.9 mm -128.12 -67.33 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -98.68 -58.88 0.14 Allowed Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 122.217 -0.302 . . . . 0.0 111.512 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 70' ' ' VAL . 87.0 Cg_endo -78.15 -4.46 14.35 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 120.958 1.105 . . . . 0.0 111.47 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 64' ' ' ARG . 8.1 pt20 -61.49 -23.5 65.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.85 -38.61 86.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.36 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 67' ' ' PRO . 30.5 m -93.22 29.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.834 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.537 ' CB ' HH21 ' A' ' 72' ' ' ARG . 85.4 m -136.98 -53.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.537 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -80.43 -21.43 42.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.826 179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 mt -110.0 -21.03 12.51 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.797 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -107.56 -64.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 79' ' ' ILE . 98.4 mt -62.76 -39.87 95.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.469 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 80' ' ' ASP . 63.8 ttm-85 -61.74 -44.48 96.83 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.075 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.4 m -64.34 -41.64 96.67 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.443 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -70.17 -41.2 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 75' ' ' LEU . 16.2 tt -91.41 -32.52 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.009 0.433 . . . . 0.0 110.355 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 76' ' ' ARG . 66.1 t0 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.934 -1.031 . . . . 0.0 111.009 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.208 0.528 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.9 mt 70.35 0.69 3.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.997 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -168.73 60.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.83 -2.98 0.31 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.73 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.554 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -128.29 -5.67 5.41 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 66' ' ' LEU . 18.9 mt -124.88 -60.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.434 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -106.93 -53.96 0.08 OUTLIER Pre-proline 0 N--CA 1.481 1.123 0 CA-C-N 117.939 0.336 . . . . 0.0 111.189 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.0 Cg_exo -74.48 -9.42 21.49 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.445 1.43 . . . . 0.0 110.544 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.694 ' NE2' HH21 ' A' ' 72' ' ' ARG . 11.9 pt20 -57.71 -25.71 60.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.615 0.722 . . . . 0.0 109.278 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.37 -46.42 76.48 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.296 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 75' ' ' LEU . 27.1 m -88.01 38.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.572 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 11.8 t -141.6 -45.97 0.36 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.289 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.694 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -105.14 -10.83 16.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.738 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.65 -35.42 6.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.529 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.87 -56.88 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.574 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 75' ' ' LEU . 8.1 mp -62.92 -39.85 95.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.532 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.983 0.421 . . . . 0.0 110.134 179.724 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 62' ' ' LEU . 70.7 p . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.3 mt 67.78 -2.08 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.693 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.5 OUTLIER -165.29 61.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.16 -5.42 0.39 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.781 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.568 ' CZ ' ' NH1' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -126.15 -2.15 7.02 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 HD23 ' A' ' 66' ' ' LEU . 19.1 mt -128.06 -64.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.487 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.85 -54.32 0.14 Allowed Pre-proline 0 N--CA 1.478 0.972 0 CA-C-N 117.987 0.358 . . . . 0.0 111.055 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.4 Cg_exo -74.14 -11.58 23.22 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.58 1.52 . . . . 0.0 110.618 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.687 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.1 pt20 -56.47 -22.85 35.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.883 0.849 . . . . 0.0 108.738 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.21 -39.37 86.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.849 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 67' ' ' PRO . 25.5 m -95.81 34.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.689 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -134.89 -46.32 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.687 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -99.87 -9.7 22.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.35 -35.21 6.85 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.247 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.73 -58.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.638 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -64.75 -22.8 67.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.832 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.52 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.028 0.442 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 74.11 0.31 3.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.819 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -167.42 59.2 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.531 ' O ' ' NH2' ' A' ' 64' ' ' ARG . . . 151.92 -3.28 0.4 Allowed Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.128 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -131.12 -3.38 3.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.388 -0.226 . . . . 0.0 110.388 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 61' ' ' LEU . 17.3 mt -130.82 -63.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -97.82 -63.14 0.11 Allowed Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.448 -178.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 70' ' ' VAL . 93.8 Cg_endo -75.1 -6.2 17.69 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 120.931 1.087 . . . . 0.0 111.26 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.703 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.0 pt20 -56.24 -23.16 34.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.05 -39.59 86.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.705 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 67' ' ' PRO . 31.0 m -95.82 36.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.584 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -137.31 -44.33 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.703 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -105.88 -10.71 16.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.805 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.6 -40.0 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.593 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.04 -55.18 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.462 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 75' ' ' LEU . 3.0 mm? -63.52 -39.36 94.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.339 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 . . . . . 0 C--O 1.218 -0.58 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.079 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.138 0.494 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 69.76 -7.58 0.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.923 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -159.91 52.47 0.34 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' NH2' ' A' ' 72' ' ' ARG . . . 161.67 -5.71 0.09 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.123 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.776 ' HE ' HH22 ' A' ' 72' ' ' ARG . 0.3 OUTLIER -129.67 0.3 4.92 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 61' ' ' LEU . 16.3 mt -136.71 -69.36 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -89.2 -58.79 0.25 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.823 -178.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -71.4 -13.48 30.53 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.233 1.289 . . . . 0.0 109.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.651 ' CG ' HH21 ' A' ' 72' ' ' ARG . 3.8 tm0? -58.79 -46.04 88.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.141 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD23 HE22 ' A' ' 68' ' ' GLN . 98.9 mt -62.35 -39.04 91.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.055 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.72 29.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 t -132.46 -44.35 0.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.776 HH22 ' HE ' ' A' ' 64' ' ' ARG . 1.1 mpp_? -101.95 -11.1 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.905 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -110.87 -28.43 8.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.554 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -107.03 -58.87 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.94 -43.85 97.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.69 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.916 -179.533 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' LEU . 82.5 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.048 0.452 . . . . 0.0 110.563 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.3 mt 68.75 -2.31 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.6 OUTLIER -166.32 62.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.67 -4.24 0.55 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.726 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -126.57 -5.84 6.41 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 HD23 ' A' ' 66' ' ' LEU . 21.1 mt -124.98 -63.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.507 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.76 -54.3 0.14 Allowed Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 117.978 0.354 . . . . 0.0 111.23 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 70' ' ' VAL . 5.6 Cg_exo -74.68 -12.5 22.24 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.662 1.574 . . . . 0.0 110.839 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.94 -23.22 30.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt -61.09 -38.96 88.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.456 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 67' ' ' PRO . 29.0 m -94.46 29.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' CB ' HH21 ' A' ' 72' ' ' ARG . 78.4 m -134.43 -61.05 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.534 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -73.14 -26.99 61.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.169 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.27 -8.34 17.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.464 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.66 -67.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.24 -39.02 93.42 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.386 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.526 -179.139 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.952 0.406 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.8 mt 71.85 6.53 5.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.789 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 62' ' ' LEU . 1.4 pp -175.61 55.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.301 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.44 -1.8 0.25 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.13 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.696 ' O ' HD13 ' A' ' 65' ' ' ILE . 12.8 tpp85 -134.26 -0.49 3.0 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 64' ' ' ARG . 8.9 mm -128.12 -67.33 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -98.68 -58.88 0.14 Allowed Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 122.217 -0.302 . . . . 0.0 111.512 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 70' ' ' VAL . 87.0 Cg_endo -78.15 -4.46 14.35 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 120.958 1.105 . . . . 0.0 111.47 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 64' ' ' ARG . 8.1 pt20 -61.49 -23.5 65.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.85 -38.61 86.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.36 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 67' ' ' PRO . 30.5 m -93.22 29.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.834 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.537 ' CB ' HH21 ' A' ' 72' ' ' ARG . 85.4 m -136.98 -53.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.537 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -80.43 -21.43 42.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.826 179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 mt -110.0 -21.03 12.51 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.797 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -107.56 -64.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.4 mt -62.76 -39.87 95.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.469 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 . . . . . 0 C--O 1.219 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.075 179.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -118.19 145.21 45.13 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.208 0.528 . . . . 0.0 111.13 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.9 mt 70.35 0.69 3.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.997 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -168.73 60.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.83 -2.98 0.31 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.73 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.554 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -128.29 -5.67 5.41 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 66' ' ' LEU . 18.9 mt -124.88 -60.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.434 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -106.93 -53.96 0.08 OUTLIER Pre-proline 0 N--CA 1.481 1.123 0 CA-C-N 117.939 0.336 . . . . 0.0 111.189 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.0 Cg_exo -74.48 -9.42 21.49 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.445 1.43 . . . . 0.0 110.544 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.694 ' NE2' HH21 ' A' ' 72' ' ' ARG . 11.9 pt20 -57.71 -25.71 60.72 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.615 0.722 . . . . 0.0 109.278 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.37 -46.42 76.48 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.296 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 75' ' ' LEU . 27.1 m -88.01 38.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.572 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 11.8 t -141.6 -45.97 0.36 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.289 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.694 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -105.14 -10.83 16.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.738 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.65 -35.42 6.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.529 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.87 -56.88 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.574 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 75' ' ' LEU . 8.1 mp -62.92 -39.85 95.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.532 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -60.87 -39.59 89.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.983 0.421 . . . . 0.0 110.134 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.97 -48.69 80.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.811 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 80' ' ' ASP . 78.7 p -86.85 43.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.739 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 pt 38.32 25.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' LEU . 65.4 t0 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.569 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 62' ' ' LEU . 70.7 p -98.53 145.11 27.13 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.172 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.3 mt 67.78 -2.08 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.693 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.5 OUTLIER -165.29 61.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.16 -5.42 0.39 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.781 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.568 ' CZ ' ' NH1' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -126.15 -2.15 7.02 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 HD23 ' A' ' 66' ' ' LEU . 19.1 mt -128.06 -64.69 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.487 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.85 -54.32 0.14 Allowed Pre-proline 0 N--CA 1.478 0.972 0 CA-C-N 117.987 0.358 . . . . 0.0 111.055 -179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 70' ' ' VAL . 7.4 Cg_exo -74.14 -11.58 23.22 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.58 1.52 . . . . 0.0 110.618 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.687 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.1 pt20 -56.47 -22.85 35.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.883 0.849 . . . . 0.0 108.738 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.21 -39.37 86.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.849 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 67' ' ' PRO . 25.5 m -95.81 34.46 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.689 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -134.89 -46.32 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.687 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -99.87 -9.7 22.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.35 -35.21 6.85 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.247 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 78' ' ' SER . 43.4 t -99.73 -58.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.638 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 75' ' ' LEU . 7.8 mp -64.75 -22.8 67.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.363 . . . . 0.0 110.832 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -60.22 -41.73 93.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.2 m -114.3 -26.9 7.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 46.7 t -61.25 -48.21 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.428 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.68 -12.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.642 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.683 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' OD2' ' NH1' ' A' ' 64' ' ' ARG . 54.9 p30 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.8 p -141.57 136.42 31.06 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.028 0.442 . . . . 0.0 110.459 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 74.11 0.31 3.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.819 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -167.42 59.2 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.531 ' O ' ' NH2' ' A' ' 64' ' ' ARG . . . 151.92 -3.28 0.4 Allowed Glycine 0 CA--C 1.525 0.67 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.128 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.545 ' CA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -131.12 -3.38 3.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.388 -0.226 . . . . 0.0 110.388 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 61' ' ' LEU . 17.3 mt -130.82 -63.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -97.82 -63.14 0.11 Allowed Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.448 -178.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' HG22 ' A' ' 70' ' ' VAL . 93.8 Cg_endo -75.1 -6.2 17.69 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 120.931 1.087 . . . . 0.0 111.26 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.703 ' NE2' HH21 ' A' ' 72' ' ' ARG . 10.0 pt20 -56.24 -23.16 34.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.05 -39.59 86.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.705 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 67' ' ' PRO . 31.0 m -95.82 36.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.584 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -137.31 -44.33 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.735 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.703 HH21 ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -105.88 -10.71 16.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.805 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -108.6 -40.0 5.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.593 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.04 -55.18 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.462 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 75' ' ' LEU . 3.0 mm? -63.52 -39.36 94.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.339 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 80' ' ' ASP . 72.2 ttp85 -59.81 -42.74 94.16 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.079 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 52.8 t -61.71 -46.61 88.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.831 0.348 . . . . 0.0 111.206 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.5 m -67.29 -42.07 84.35 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 75' ' ' LEU . 16.2 tt -95.63 -30.91 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.801 0.334 . . . . 0.0 111.625 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 76' ' ' ARG . 1.2 m-20 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.861 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 p30 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -178.03 102.27 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.029 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.5 OUTLIER 69.76 -7.58 0.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.923 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -159.91 52.47 0.34 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' NH2' ' A' ' 72' ' ' ARG . . . 161.67 -5.71 0.09 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.123 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.776 ' HE ' HH22 ' A' ' 72' ' ' ARG . 0.3 OUTLIER -129.67 0.3 4.92 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 61' ' ' LEU . 16.3 mt -136.71 -69.36 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -89.2 -58.79 0.25 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.823 -178.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -71.4 -13.48 30.53 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.233 1.289 . . . . 0.0 109.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.651 ' CG ' HH21 ' A' ' 72' ' ' ARG . 3.8 tm0? -58.79 -46.04 88.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.141 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD23 HE22 ' A' ' 68' ' ' GLN . 98.9 mt -62.35 -39.04 91.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.055 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.72 29.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 t -132.46 -44.35 0.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.776 HH22 ' HE ' ' A' ' 64' ' ' ARG . 1.1 mpp_? -101.95 -11.1 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.905 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -110.87 -28.43 8.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.554 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -107.03 -58.87 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.94 -43.85 97.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.69 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -81.8 6.76 14.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.916 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 41.0 t -116.92 -50.75 2.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -61.21 -43.94 98.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.425 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.8 pt -118.86 -8.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.587 0.232 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.552 -179.876 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB3' HH21 ' A' ' 64' ' ' ARG . 99.7 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' LEU . 82.5 p -116.47 144.77 43.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.048 0.452 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.3 mt 68.75 -2.31 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 60' ' ' THR . 0.6 OUTLIER -166.32 62.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.67 -4.24 0.55 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.726 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 59' ' ' ASP . 13.3 tpp85 -126.57 -5.84 6.41 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 HD23 ' A' ' 66' ' ' LEU . 21.1 mt -124.98 -63.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.507 HD23 HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -101.76 -54.3 0.14 Allowed Pre-proline 0 N--CA 1.478 0.967 0 CA-C-N 117.978 0.354 . . . . 0.0 111.23 -178.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 70' ' ' VAL . 5.6 Cg_exo -74.68 -12.5 22.24 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.662 1.574 . . . . 0.0 110.839 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.94 -23.22 30.69 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.3 mt -61.09 -38.96 88.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.456 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 67' ' ' PRO . 29.0 m -94.46 29.17 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' CB ' HH21 ' A' ' 72' ' ' ARG . 78.4 m -134.43 -61.05 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.534 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -73.14 -26.99 61.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.169 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.27 -8.34 17.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.464 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.66 -67.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.24 -39.02 93.42 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.386 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 34.7 ttm180 -81.5 -13.21 58.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.526 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.78 -53.03 2.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -60.98 -41.02 95.65 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.3 -8.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.606 0.241 . . . . 0.0 111.629 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 76' ' ' ARG . 98.7 m-20 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.718 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB3' HH21 ' A' ' 64' ' ' ARG . 99.1 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -117.6 148.87 41.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.952 0.406 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.8 mt 71.85 6.53 5.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.789 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 62' ' ' LEU . 1.4 pp -175.61 55.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.301 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.44 -1.8 0.25 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.13 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.696 ' O ' HD13 ' A' ' 65' ' ' ILE . 12.8 tpp85 -134.26 -0.49 3.0 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 64' ' ' ARG . 8.9 mm -128.12 -67.33 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -98.68 -58.88 0.14 Allowed Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 122.217 -0.302 . . . . 0.0 111.512 -178.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 70' ' ' VAL . 87.0 Cg_endo -78.15 -4.46 14.35 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 120.958 1.105 . . . . 0.0 111.47 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 64' ' ' ARG . 8.1 pt20 -61.49 -23.5 65.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.85 -38.61 86.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.36 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 67' ' ' PRO . 30.5 m -93.22 29.55 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.834 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.537 ' CB ' HH21 ' A' ' 72' ' ' ARG . 85.4 m -136.98 -53.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.537 HH21 ' CB ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -80.43 -21.43 42.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.826 179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 mt -110.0 -21.03 12.51 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.797 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -107.56 -64.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 79' ' ' ILE . 98.4 mt -62.76 -39.87 95.49 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.469 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 80' ' ' ASP . 63.8 ttm-85 -61.74 -44.48 96.83 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.075 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.4 m -64.34 -41.64 96.67 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.443 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -70.17 -41.2 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 75' ' ' LEU . 16.2 tt -91.41 -32.52 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.009 0.433 . . . . 0.0 110.355 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' A' ' 76' ' ' ARG . 66.1 t0 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.934 -1.031 . . . . 0.0 111.009 -179.705 . . . . . . . . 1 1 . 1 stop_ save_